Insulin Antagonists

"Insulin Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Compounds which inhibit or antagonize the biosynthesis or action of insulin.

Descriptor ID

D007329

MeSH Number(s)

D06.347.420

D27.505.696.399.450.420

Concept/Terms

Insulin Antagonists

Below are MeSH descriptors whose meaning is more general than "Insulin Antagonists".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormone Antagonists [D06.347]
Insulin Antagonists [D06.347.420]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hormone Antagonists [D27.505.696.399.450]
Insulin Antagonists [D27.505.696.399.450.420]

Below are MeSH descriptors whose meaning is related to "Insulin Antagonists".

Below are MeSH descriptors whose meaning is more specific than "Insulin Antagonists".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin Antagonists" by people in Harvard Catalyst Profiles by year, and whether "Insulin Antagonists" was a major or minor topic of these publication.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 1998 and 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	2	2
2002	2	0	2
2010	0	1	1
2021	0	1	1
2023	1	0	1

Below are the most recent publications written about "Insulin Antagonists" by people in Profiles.

Anti-Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia. N Engl J Med. 2023 Aug 24; 389(8):767-769.

View in: PubMed
Synthesis and Evaluation of Arylamides with Hydrophobic Side Chains for Insulin Aggregation Inhibition. Chempluschem. 2021 05; 86(5):750-757.

View in: PubMed
Demonstration of a visual cell-based assay for screening glucose transporter 4 translocation modulators in real time. J Biosci. 2010 Dec; 35(4):525-31.

View in: PubMed
Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J. 2006 Jun; 20(8):1206-8.

View in: PubMed
Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem. 2005 Nov 04; 280(44):36824-32.

View in: PubMed
Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation. 2003 Oct 14; 108(15):1815-21.

View in: PubMed
Antitumorigenic and antiinsulinogenic effects of calcitriol on insulinoma cells and solid beta-cell tumors. Endocrinology. 2002 Oct; 143(10):4018-30.

View in: PubMed
Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3. J Biol Chem. 2002 Sep 06; 277(36):32915-22.

View in: PubMed
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2000 May; 35(5):749-57.

View in: PubMed
Mechanism of hypothyroidism action on insulin-like growth factor-I and -II from neonatal to adult rats: insulin mediates thyroid hormone effects in the neonatal period. Endocrinology. 1998 Dec; 139(12):4782-92.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Biol Chem
Endocrinology
N Engl J Med
J Cardiovasc Pharmacol
FASEB J
Circulation
Am J Physiol
Diabetes
Chempluschem
Annu Rev Med